Drug Profile


Alternative Names: PAI-2; Plasminogen activator inhibitor (PAI) type 2

Latest Information Update: 19 Mar 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Human Therapeutics; Network Limited
  • Developer Network Limited
  • Class Antineoplastics; Blood coagulation factors
  • Mechanism of Action Plasminogen activator inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer; Psoriasis; Skin ulcer

Most Recent Events

  • 19 Mar 2003 No development reported - Phase-II for Psoriasis in Australia (Topical)
  • 19 Mar 2003 No development reported - Phase-II for Skin ulcer in Australia (Topical)
  • 30 Jun 2002 Biotech Australia has been acquired by, and merged into, GroPep
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top